Evidence map›Paper›PMID 30173408›Full record

ArticleMolecular neurobiology2019

Pantothenate Rescues Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration Depending on the Type of Mutation.

Mónica Álvarez-Córdoba, Aida Fernández Khoury, Marina Villanueva-Paz, Carmen Gómez-Navarro, Irene Villalón-García, Juan M Suárez-Rivero, Suleva Povea-Cabello, Mario de la Mata, David Cotán, Marta Talaverón-Rey and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Mónica Álvarez-CórdobaCentro Andaluz de Biología del Desarrollo (CABD-CSIC), Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013, Sevilla, Spain.
Aida Fernández KhouryCentro Andaluz de Biología del Desarrollo (CABD-CSIC), Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013, Sevilla, Spain.
Marina Villanueva-PazCentro Andaluz de Biología del Desarrollo (CABD-CSIC), Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013, Sevilla, Spain.
Carmen Gómez-NavarroCentro Andaluz de Biología del Desarrollo (CABD-CSIC), Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013, Sevilla, Spain.
Irene Villalón-GarcíaCentro Andaluz de Biología del Desarrollo (CABD-CSIC), Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013, Sevilla, Spain.
Juan M Suárez-RiveroCentro Andaluz de Biología del Desarrollo (CABD-CSIC), Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013, Sevilla, Spain.
Suleva Povea-CabelloCentro Andaluz de Biología del Desarrollo (CABD-CSIC), Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013, Sevilla, Spain.
Mario de la MataCentro Andaluz de Biología del Desarrollo (CABD-CSIC), Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013, Sevilla, Spain.
David CotánCentro Andaluz de Biología del Desarrollo (CABD-CSIC), Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013, Sevilla, Spain.
Marta Talaverón-ReyCentro Andaluz de Biología del Desarrollo (CABD-CSIC), Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013, Sevilla, Spain.
Antonio J Pérez-PulidoDepartamento de Biología Molecular e Ingeniería Bioquímica, Universidad Pablo de Olavide, Sevilla, Spain.
Joaquín J SalasDepartamento de Bioquímica y Biología Molecular de Productos Vegetales, Instituto de la Grasa (CSIC), Sevilla, Spain.
Eva Mª Pérez-VillegasDepartamento de Fisiología, Anatomía y Biología Celular, Universidad Pablo de Olavide, 41013, Sevilla, Spain.
Antonio Díaz-QuintanaInstituto de Investigaciones Químicas (IIQ)-Centro de Investigaciones Científicas Isla de la Cartuja (cicCartuja), Universidad de Sevilla-CSIC, Sevilla, Spain.
José A ArmengolDepartamento de Fisiología, Anatomía y Biología Celular, Universidad Pablo de Olavide, 41013, Sevilla, Spain.
José A Sánchez-AlcázarCentro Andaluz de Biología del Desarrollo (CABD-CSIC), Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013, Sevilla, Spain. jasanalc@upo.es.ORCID http://orcid.org/0000-0001-9705-1469
Instituto de Salud Carlos III · ESUniversidad Pablo de Olavide · ESCentro de Investigaciones Científicas Isla de la Cartuja · ESInstituto de la Grasa · ES

Funding

Agencia de Innovación y Desarrollo de Andalucía BIO-122Agencia de Innovación y Desarrollo de Andalucía CTS-5725DGICYT BFU2015-64536-RInstituto de Salud Carlos III PI16/00786
6 · The paper itself

Abstract

Neurodegeneration with brain iron accumulation (NBIA) is a group of inherited neurologic disorders in which iron accumulates in the basal ganglia resulting in progressive dystonia, spasticity, parkinsonism, neuropsychiatric abnormalities, and optic atrophy or retinal degeneration. The most prevalent form of NBIA is pantothenate kinase-associated neurodegeneration (PKAN) associated with mutations in the gene of pantothenate kinase 2 (PANK2), which is essential for coenzyme A (CoA) synthesis. There is no cure for NBIA nor is there a standard course of treatment. In the current work, we describe that fibroblasts derived from patients harbouring PANK2 mutations can reproduce many of the cellular pathological alterations found in the disease, such as intracellular iron and lipofuscin accumulation, increased oxidative stress, and mitochondrial dysfunction. Furthermore, mutant fibroblasts showed a characteristic senescent morphology. Treatment with pantothenate, the PANK2 enzyme substrate, was able to correct all pathological alterations in responder mutant fibroblasts with residual PANK2 enzyme expression. However, pantothenate had no effect on mutant fibroblasts with truncated/incomplete protein expression. The positive effect of pantothenate in particular mutations was also confirmed in induced neurons obtained by direct reprograming of mutant fibroblasts. Our results suggest that pantothenate treatment can stabilize the expression levels of PANK2 in selected mutations. These results encourage us to propose our screening model as a quick and easy way to detect pantothenate-responder patients with PANK2 mutations. The existence of residual enzyme expression in some affected individuals raises the possibility of treatment using high dose of pantothenate.

Indexed as

Cell DeathCell ShapeCoenzyme AEnergy MetabolismFibroblastsGene Expression Regulation, EnzymologicHumansIronLipid PeroxidationLipofuscinMitochondriaMutationNeuronsNeuroprotective AgentsOxidative StressPantothenate Kinase-Associated NeurodegenerationCoenzyme AIronLipofuscinNeuroprotective Agentspantothenate kinasePantothenic AcidPhosphotransferases (Alcohol Group Acceptor)Coenzyme AInduced neuronsMitochondriaPantothenatePantothenate kinase

Identifiers

PMID30173408
OpenAlexW2889510216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.